ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $0

      Shares

      0

      % of Portfolio

      0.00%

      Average Buy Price

      $0

      Avg closing price
      Price range

      2 Jefferies Group Zenas BioPharma Trades

      Jefferies Group started to build up the position in Zenas BioPharma in Q1 2025. Since then they sold 44.1k shares. The investor sold all their shares in Q2 2025 and doesn't own any shares in Zenas BioPharma anymore.

      Avg closing price
      Price range
      Sold -44.1k shares Q2 2025
      Avg closing price $10.19
      Price range $9.19 - $12.11
      New holding (+44.1k shares) Q1 2025
      Avg closing price -
      Price range - - -

      News about Zenas BioPharma, Inc. and Jefferies Group

      FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

      FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

      LOS ANGELES , June 16, 2025 /PRNewswire/ -- The DJS Law Group?reminds investors of a class action lawsuit against Zenas Biopharma, Inc. ("Zenas" or "the Comp...

      prnewswire.com prnewswire.com, 3 months ago
      ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

      ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

      LOS ANGELES , June 11, 2025 /PRNewswire/ -- The DJS Law Group?reminds investors of a class action lawsuit against Zenas Biopharma, Inc. ("Zenas" or "the Comp...

      prnewswire.com prnewswire.com, 3 months ago
      ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

      ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

      LOS ANGELES , June 6, 2025 /PRNewswire/ -- ?The DJS Law Group?reminds investors of a class action lawsuit against Zenas Biopharma, Inc. ("Zenas" or "the Comp...

      prnewswire.com prnewswire.com, 3 months ago
      ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

      ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

      LOS ANGELES , June 2, 2025 /PRNewswire/ -- The DJS Law Group?reminds investors of a class action lawsuit against Zenas Biopharma, Inc. ("Zenas" or "the Compa...

      prnewswire.com prnewswire.com, 3 months ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×